Millions of
1500
Biospecimens Procurement
As a leading global supplier of biospecimens, iProcess Global Research is working with major pharmaceutical, diagnostic and research organizations to help support cutting edge research. Time and again, we deliver results for the most simple to the most complex collection protocols required by our clients. From projects involving liquid biopsy research to personalized medicine, we provide our clients with a whole range of biospecimens that are banked or prospectively collected.
A network of hundreds of sites across the globe including North America, Europe, Africa, South America, Asia and Australia.
Banked or prospectively collected tissues, blood, plasma, serum, swabs, urine and stools (including Covid-19) across disease types including cancer and infections diseases.
A major biospecimens supplier to the top pharmaceutical lifescience and biotech companies in the world.
Our Services
Testing
Our Services
Global Network
iProcess has thrived and expanded upon its mission and has a network of 1500 sites globally.
Our Services
Biospecimens
iProcess Global Research is your trusted partner for biospecimens. We have over 17 years of experience and maintain a global network of 1500 sites.
Our Services
Artificial Intelligence
Artificial Intelligence and Machine Learning is going to change the way we discover new drugs and diagnose diseases.
Check Out Our Other Available Services
Biospecimens
iProcess Global Research is your trusted partner for biospecimens. We have over 17 years of experience and maintain a global network of 1500 sites.
Testing
iProcess is launching a CLIA Certified laboratory in 2022 to provide testing for our research partners.
Artificial Intelligence
Artificial Intelligence and Machine Learning is going to change the way we discover new drugs and diagnose diseases.
Global Network
iProcess has thrived and expanded upon its mission and has a network of 1500 sites globally.
Submit A Free Feasibility Request
The iProcess Feasibility Testing provides a convenient way to minimize risks to our clients whilst still providing the maximum flexibility to explore the newest possible technical solutions.